Comparative Efficacy of Systemic Agents for Brain Metastases From Non-Small-Cell Lung Cancer With an EGFR Mutation/ALK Rearrangement: A Systematic Review and Network Meta-Analysis

BACKGROUND: Brain metastases (BM) from non-small-cell lung cancer (NSCLC) are frequent and carry significant morbidity, and current management options include varying local and systemic therapies. Here, we performed a systematic review and network meta-analysis to determine the ideal treatment regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Taslimi, Shervin, Brar, Karanbir, Ellenbogen, Yosef, Deng, Jiawen, Hou, Winston, Moraes, Fabio Y., Glantz, Michael, Zacharia, Brad E., Tan, Aaron, Ahluwalia, Manmeet S., Khasraw, Mustafa, Zadeh, Gelareh, Mansouri, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691653/
https://www.ncbi.nlm.nih.gov/pubmed/34950579
http://dx.doi.org/10.3389/fonc.2021.739765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691653/
https://www.ncbi.nlm.nih.gov/pubmed/34950579
http://dx.doi.org/10.3389/fonc.2021.739765

Ejemplares similares